Literature DB >> 2481309

HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region.

B P Wordsworth1, J S Lanchbury, L I Sakkas, K I Welsh, G S Panayi, J I Bell.   

Abstract

Susceptibility to rheumatoid arthritis (RA) may be due to the presence of shared functional epitopes common to the HLA-DR beta chains of several RA-associated haplotypes. We have obtained direct evidence for this hypothesis by using the polymerase chain reaction and sequencing the DRB1 and DQB1 genes from RA patients. A highly conserved epitope present on DR beta chains of DR4 and DR1 haplotypes was found in 83% of 149 patients with classical or definite RA but was found in only 46% of 100 control individuals (P less than 0.0001). Two Dw subtypes of DR4 (Dw4 and Dw14) were associated with disease susceptibility but two other subtypes (Dw10 and Dw13) were not. Sequence differences between these subtypes implicate those residues around the putative antigen binding site of the DR beta molecule in the pathogenesis of RA. These data provide a basis for understanding host susceptibility to RA at a molecular level.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2481309      PMCID: PMC298641          DOI: 10.1073/pnas.86.24.10049

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

2.  EcoK selection vectors for shotgun cloning into M13 and deletion mutagenesis.

Authors:  M M Waye; M E Verhoeyen; P T Jones; G Winter
Journal:  Nucleic Acids Res       Date:  1985-12-09       Impact factor: 16.971

3.  Allelic variation in the DR subregion of the human major histocompatibility complex.

Authors:  J I Bell; D Denney; L Foster; T Belt; J A Todd; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

4.  A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules.

Authors:  J H Brown; T Jardetzky; M A Saper; B Samraoui; P J Bjorkman; D C Wiley
Journal:  Nature       Date:  1988-04-28       Impact factor: 49.962

5.  Strong association of rheumatoid arthritis with the presence of a polymorphic Ia epitope defined by a monoclonal antibody: comparison with the allodeterminant DR4.

Authors:  S H Lee; P K Gregersen; H H Shen; A Nunez-Roldan; J Silver; R J Winchester
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

6.  Serological and cellular definition of a new HLA-DR associated determinant, MC1, and its association with rheumatoid arthritis.

Authors:  R J Duquesnoy; M Marrari; S Hackbarth; A Zeevi
Journal:  Hum Immunol       Date:  1984-07       Impact factor: 2.850

7.  Association of HLA-Aw31 and HLA-DR1 with adult rheumatoid arthritis.

Authors:  B Schiff; Y Mizrachi; S Orgad; M Yaron; E Gazit
Journal:  Ann Rheum Dis       Date:  1982-08       Impact factor: 19.103

8.  HLA antigens and rheumatoid arthritis. Association between HLA-DRw4 positivity and IgM rheumatoid factor production.

Authors:  J H Dobloug; O Førre; E Kåss; E Thorsby
Journal:  Arthritis Rheum       Date:  1980-03

9.  Regions of allelic hypervariability in the murine A alpha immune response gene.

Authors:  C O Benoist; D J Mathis; M R Kanter; V E Williams; H O McDevitt
Journal:  Cell       Date:  1983-08       Impact factor: 41.582

10.  Both alpha and beta chains of HLA-DC class II histocompatibility antigens display extensive polymorphism in their amino-terminal domains.

Authors:  L Schenning; D Larhammar; P Bill; K Wiman; A K Jonsson; L Rask; P A Peterson
Journal:  EMBO J       Date:  1984-02       Impact factor: 11.598

View more
  94 in total

Review 1.  Human cartilage proteoglycans as T cell autoantigens.

Authors:  J A Goodacre; J P Pearson
Journal:  Ann Rheum Dis       Date:  1992-09       Impact factor: 19.103

2.  A possible association between basic amino acids of position 13 of DRB1 chains and autoimmune hepatitis.

Authors:  M Ota; T Seki; K Kiyosawa; S Furuta; K Hino; T Kondo; H Fukushima; K Tsuji; H Inoko
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

Review 3.  The immunogenetics of rheumatoid arthritis.

Authors:  B P Wordsworth; J I Bell
Journal:  Springer Semin Immunopathol       Date:  1992

Review 4.  The polymerase chain reaction and other amplification techniques in immunological research and diagnosis.

Authors:  A M Lew; R B Brandon; M Panaccio; C J Morrow
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

5.  Nucleotide sequence of a novel HLA-DRB4B1 allele, DRB1*0409.

Authors:  J S Lanchbury; E E Jaeger; K I Welsh; G S Panayi
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

Review 6.  Polygenic susceptibility in rheumatoid arthritis.

Authors:  P Wordsworth; J Bell
Journal:  Ann Rheum Dis       Date:  1991-06       Impact factor: 19.103

7.  Association between IgA deficiency & other autoimmune conditions: a population-based matched cohort study.

Authors:  Jonas F Ludvigsson; Martin Neovius; Lennart Hammarström
Journal:  J Clin Immunol       Date:  2014-03-02       Impact factor: 8.317

8.  Investigation of the HLA component involved in rheumatoid arthritis (RA) by using the marker association-segregation chi-square (MASC) method: rejection of the unifying-shared-epitope hypothesis.

Authors:  M H Dizier; J F Eliaou; M C Babron; B Combe; J Sany; J Clot; F Clerget-Darpoux
Journal:  Am J Hum Genet       Date:  1993-09       Impact factor: 11.025

9.  HLA-DRB1 typing in rheumatoid arthritis: predicting response to specific treatments.

Authors:  J R O'Dell; B S Nepom; C Haire; V H Gersuk; L Gaur; G F Moore; W Drymalski; W Palmer; P J Eckhoff; L W Klassen; S Wees; G Thiele; G T Nepom
Journal:  Ann Rheum Dis       Date:  1998-04       Impact factor: 19.103

10.  Examination of HLA-DR4 as a severity marker for rheumatoid arthritis in Greek patients.

Authors:  K A Boki; A A Drosos; A G Tzioufas; J S Lanchbury; G S Panayi; H M Moutsopoulos
Journal:  Ann Rheum Dis       Date:  1993-07       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.